Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 912.60
+27.95 (3.16%)
Aug 21, 2026, 3:29 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 20.31 billion as of August 21, 2026. Its market cap has increased by 191.15% in one year.
Market Cap
20.31B
Enterprise Value
21.01B
Revenue
2.72B
Ranking
n/a
PE Ratio
56.33
Stock Price
912.60
ChartMarket Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 20.31B, an increase of 3,525.25%. That is a compound annual growth rate of 49.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 20.31B | 123.02% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 62.29B |
| Orchid Pharma | 50.82B |
| RPG Life Sciences | 43.61B |
| Solara Active Pharma Sciences | 29.72B |
| Ind-Swift Laboratories | 28.66B |
| Beta Drugs | 23.50B |
| Indoco Remedies | 20.89B |
| Windlas Biotech | 20.50B |